These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 15129063)

  • 1. Ne-Osteo bone growth factor for posterolateral lumbar spine fusion: results from a nonhuman primate study and a prospective human clinical pilot study.
    Boden SD; Grob D; Damien C
    Spine (Phila Pa 1976); 2004 Mar; 29(5):504-14. PubMed ID: 15129063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.
    Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz H; Phillips F; Hilibrand A; Albert TJ
    Eur Spine J; 2003 Oct; 12(5):495-500. PubMed ID: 12908103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis.
    Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz HN; Phillips F; Hilibrand A; Albert TJ; Wetzel T; McCulloch JA
    Spine (Phila Pa 1976); 2004 Sep; 29(17):1885-92. PubMed ID: 15534410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
    Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
    Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
    Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
    Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
    Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
    Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purified bovine BMP extract and collagen for spine arthrodesis: preclinical safety and efficacy.
    Damien CJ; Grob D; Boden SD; Benedict JJ
    Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S50-8. PubMed ID: 12205421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.
    Vaccaro AR; Whang PG; Patel T; Phillips FM; Anderson DG; Albert TJ; Hilibrand AS; Brower RS; Kurd MF; Appannagari A; Patel M; Fischgrund JS
    Spine J; 2008; 8(3):457-65. PubMed ID: 17588821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of osteoinduction by Grafton demineralized bone matrix in nonhuman primate spinal fusion.
    Louis-Ugbo J; Murakami H; Kim HS; Minamide A; Boden SD
    Spine (Phila Pa 1976); 2004 Feb; 29(4):360-6; discussion Z1. PubMed ID: 15094531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.
    Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY
    J Bone Joint Surg Am; 2009 Jun; 91(6):1377-86. PubMed ID: 19487515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
    Boden SD; Kang J; Sandhu H; Heller JG
    Spine (Phila Pa 1976); 2002 Dec; 27(23):2662-73. PubMed ID: 12461392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model.
    Hecht BP; Fischgrund JS; Herkowitz HN; Penman L; Toth JM; Shirkhoda A
    Spine (Phila Pa 1976); 1999 Apr; 24(7):629-36. PubMed ID: 10209790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.
    Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz H; Phillips F; Hilibrand A; Albert TJ
    Eur Spine J; 2005 Sep; 14(7):623-9. PubMed ID: 15672240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study.
    Vaccaro AR; Anderson DG; Patel T; Fischgrund J; Truumees E; Herkowitz HN; Phillips F; Hilibrand A; Albert TJ; Wetzel T; McCulloch JA
    Spine (Phila Pa 1976); 2005 Dec; 30(24):2709-16. PubMed ID: 16371892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion.
    Boden SD; Martin GJ; Morone M; Ugbo JL; Titus L; Hutton WC
    Spine (Phila Pa 1976); 1999 Feb; 24(4):320-7. PubMed ID: 10065514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion.
    Kraiwattanapong C; Boden SD; Louis-Ugbo J; Attallah E; Barnes B; Hutton WC
    Spine (Phila Pa 1976); 2005 May; 30(9):1001-7; discussion 1007. PubMed ID: 15864149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Instrumented one and two level posterolateral fusions with recombinant human bone morphogenetic protein-2 and allograft: a computed tomography study.
    Stambough JL; Clouse EK; Stambough JB
    Spine (Phila Pa 1976); 2010 Jan; 35(1):124-9. PubMed ID: 20042965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.
    Barnes B; Boden SD; Louis-Ugbo J; Tomak PR; Park JS; Park MS; Minamide A
    Spine (Phila Pa 1976); 2005 May; 30(10):1127-33. PubMed ID: 15897825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW; Branch CL; Alexander JT; Burkus JK
    Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years.
    Singh K; Smucker JD; Gill S; Boden SD
    J Spinal Disord Tech; 2006 Aug; 19(6):416-23. PubMed ID: 16891977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.